Search

Drotaverine

[A231619] Drotaverine is not approved by the FDA, European Medicines Agency, or Health Canada. It is approved for use in Thailand as oral tablets or intramuscular injections.[L22689]

Tedizolid phosphate

[L11232, A199086, A199050] Tedizolid was approved by the FDA on June 20, 2014, for sale by Cubist Pharmaceuticals as tedizolid phosphate (SIVEXTRO®).

Ibrexafungerp

[A235414,L34349] Ibrexafungerp was granted FDA approval on 1 June 2021.[L34349]

R-30490

R-30490 was found to be the most selective agonist for the mu opioid receptor out of all the fentanyl analogues tested, but it has never been introduced for medical use in humans, although the closely

Passiflora incarnata flower

Serotonin

Not evaluated by the FDA, homeopathic product.

AMZ002

AMZ002 is a sterile injectable hormone developed as a purified synthetic polypeptide alternative to current FDA-approved epileptic seizure treatments.

Psilocybin

In November, 2019, it was granted Breakthrough Therapy status by the FDA.

WP-1122

It was granted FDA orphan designation for the treatment of glioblastoma multiforme.[L47361]

Dyphylline

Dyphylline is a theophylline derivative with broncho- and vasodilator properties. It is typically used in the management of asthma, cardiac dyspnea, and bronchitis.